Literature DB >> 2162683

An Escherichia coli expression vector for high-level production of heterologous proteins in fusion with CMP-KDO synthetase.

T J Bolling1, W Mandecki.   

Abstract

The construction of a vector which overproduces the enzyme, CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyl-transferase (CMP-KDO synthetase or CKS) and its use as an expression vector for producing heterologous proteins in E. coli is described. The vector, which includes a modified lac promoter and synthetic ribosome binding site upstream of the native kdsB gene (encoding CKS), produces CKS at levels as high as 70% of the total cellular proteins. Several heterologous gene sequences have been fused to the 3'-end of the kdsB gene with resulting protein fusions produced at a level of up to 40% of the total cellular proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162683

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  11 in total

1.  The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens.

Authors:  G T Maine; T Lazzarotto; L E Chovan; R Flanders; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

2.  Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen.

Authors:  S Li; G Maine; Y Suzuki; F G Araujo; G Galvan; J S Remington; S Parmley
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Expression and characterization of a novel structural protein of human cytomegalovirus, pUL25.

Authors:  M C Battista; G Bergamini; M C Boccuni; F Campanini; A Ripalti; M P Landini
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates.

Authors:  A Scott Muerhoff; Larry G Birkenmeyer; Ruthie Coffey; Bruce J Dille; John W Barnwell; William E Collins; Joann S Sullivan; George J Dawson; Suresh M Desai
Journal:  Clin Vaccine Immunol       Date:  2010-08-11

5.  Substrate requirements for ErmC' methyltransferase activity.

Authors:  P Zhong; S D Pratt; R P Edalji; K A Walter; T F Holzman; A G Shivakumar; L Katz
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

6.  Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs.

Authors:  J P Allain; S H Dailey; Y Laurian; D S Vallari; A Rafowicz; S M Desai; S G Devare
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  High-level expression of recombinant human FK-binding protein from a fusion precursor.

Authors:  R Edalji; T J Pilot-Matias; S D Pratt; D A Egan; J M Severin; E G Gubbins; A M Petros; S W Fesik; N S Burres; T F Holzman
Journal:  J Protein Chem       Date:  1992-06

8.  Serological markers of posttransfusion hepatitis C viral infection.

Authors:  D S Vallari; B W Jett; H J Alter; L T Mimms; R Holzman; J W Shih
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

9.  Analysis of the humoral response to the flagellin protein of Borrelia burgdorferi: cloning of regions capable of differentiating Lyme disease from syphilis.

Authors:  J M Robinson; T J Pilot-Matias; S D Pratt; C B Patel; T S Bevirt; J C Hunt
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

10.  Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay.

Authors:  M P Landini; T Lazzarotto; G T Maine; A Ripalti; R Flanders
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.